StocksFundsScreenerSectorsWatchlists
CHE

CHE - Chemed Corp Stock Price, Fair Value and News

597.86USD-6.31 (-1.04%)Market Closed

Market Summary

CHE
USD597.86-6.31
Market Closed
-1.04%

CHE Alerts

  • 3 major insider sales recently.

CHE Stock Price

View Fullscreen

CHE RSI Chart

CHE Valuation

Market Cap

9.0B

Price/Earnings (Trailing)

33.17

Price/Sales (Trailing)

3.99

EV/EBITDA

21.31

Price/Free Cashflow

33.05

CHE Price/Sales (Trailing)

CHE Profitability

Operating Margin

55.74%

EBT Margin

15.47%

Return on Equity

24.6%

Return on Assets

16.34%

Free Cashflow Yield

3.03%

CHE Fundamentals

CHE Revenue

Revenue (TTM)

2.3B

Rev. Growth (Yr)

7.18%

Rev. Growth (Qtr)

3.79%

CHE Earnings

Earnings (TTM)

272.5M

Earnings Growth (Yr)

44.95%

Earnings Growth (Qtr)

20.14%

Breaking Down CHE Revenue

Last 7 days

-3.4%

Last 30 days

-8.1%

Last 90 days

0.6%

Trailing 12 Months

6.7%

How does CHE drawdown profile look like?

CHE Financial Health

Current Ratio

1.61

Debt/Equity

0.01

Debt/Cashflow

20.33

CHE Investor Care

Dividend Yield

0.26%

Dividend/Share (TTM)

1.56

Shares Dilution (1Y)

1.13%

Diluted EPS (TTM)

17.93

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20232.2B2.2B2.2B2.3B
20222.1B2.1B2.1B2.1B
20212.1B2.1B2.1B2.1B
20202.0B2.0B2.1B2.1B
20191.8B1.9B1.9B1.9B
20181.7B1.7B1.8B1.8B
20171.6B1.6B1.6B1.7B
20161.6B1.6B1.6B1.6B
20151.5B1.5B1.5B1.5B
20141.4B1.4B1.4B1.5B
20131.4B1.4B1.4B1.4B
20121.4B1.4B1.4B1.4B
20111.3B1.3B1.3B1.4B
20101.2B1.2B1.2B1.3B
200901.2B1.2B1.2B
20080001.1B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Chemed Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 28, 2024
lee spencer s
acquired
1,385,670
106
13,000
executive vice president
Mar 28, 2024
lee spencer s
sold (taxes)
-4,557,960
643
-7,080
executive vice president
Mar 28, 2024
lee spencer s
sold
-1,283,300
641
-2,000
executive vice president
Mar 21, 2024
witzeman michael d
sold
-1,704,320
643
-2,650
vp & chief financial officer
Mar 20, 2024
witzeman michael d
acquired
1,074,290
413
2,600
vp & chief financial officer
Mar 20, 2024
judkins brian c
acquired
5,300,010
443
11,958
vp and chief legal officer
Mar 20, 2024
witzeman michael d
sold (taxes)
-229,841
647
-355
vp & chief financial officer
Mar 20, 2024
judkins brian c
sold
-7,196,910
645
-11,158
vp and chief legal officer
Mar 06, 2024
hutton thomas c
acquired
1,466,990
449
3,267
vice president
Mar 06, 2024
hutton thomas c
sold (taxes)
-1,693,560
633
-2,673
vice president

1–10 of 50

Which funds bought or sold CHE recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 17, 2024
NEW MEXICO EDUCATIONAL RETIREMENT BOARD
added
10.00
-82,000
1,672,000
0.06%
Apr 17, 2024
Hennion & Walsh Asset Management, Inc.
sold off
-100
-262,553
-
-%
Apr 16, 2024
TSFG, LLC
unchanged
-
11,000
128,000
0.03%
Apr 16, 2024
Financial Management Professionals, Inc.
unchanged
-
-
3,000
-%
Apr 16, 2024
CAPITAL INSIGHT PARTNERS, LLC
added
7.55
979,524
6,401,330
1.20%
Apr 16, 2024
Ausbil Investment Management Ltd
reduced
-4.93
23,199
581,051
0.29%
Apr 16, 2024
MCF Advisors LLC
unchanged
-
28,590
320,965
0.03%
Apr 16, 2024
Thrive Wealth Management, LLC
new
-
225,959
225,959
0.05%
Apr 16, 2024
HENGEHOLD CAPITAL MANAGEMENT LLC
unchanged
-
50,947
571,960
0.06%
Apr 16, 2024
Berger Financial Group, Inc
reduced
-1.23
23,963
307,887
0.03%

1–10 of 50

Are Funds Buying or Selling CHE?

Are funds buying CHE calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CHE
No. of Funds

Unveiling Chemed Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
11.28%
1,699,648
SC 13G/A
Jan 24, 2024
blackrock inc.
9.4%
1,409,958
SC 13G/A
Feb 09, 2023
vanguard group inc
11.38%
1,692,377
SC 13G/A
Jan 24, 2023
blackrock inc.
9.4%
1,399,535
SC 13G
Feb 09, 2022
vanguard group inc
11.31%
1,740,446
SC 13G/A
Feb 01, 2022
blackrock inc.
8.7%
1,343,981
SC 13G/A
Feb 10, 2021
vanguard group inc
11.41%
1,819,635
SC 13G/A
Jan 29, 2021
blackrock inc.
9.2%
1,463,600
SC 13G/A
Feb 12, 2020
vanguard group inc
12.04%
1,928,122
SC 13G/A
Feb 05, 2020
blackrock inc.
9.9%
1,578,926
SC 13G/A

Recent SEC filings of Chemed Corp

View All Filings
Date Filed Form Type Document
Apr 17, 2024
8-K
Current Report
Apr 08, 2024
DEF 14A
DEF 14A
Apr 01, 2024
4
Insider Trading
Mar 22, 2024
4
Insider Trading
Mar 22, 2024
4
Insider Trading
Mar 20, 2024
144
Notice of Insider Sale Intent
Mar 13, 2024
8-K
Current Report
Mar 07, 2024
4
Insider Trading
Feb 29, 2024
10-K
Annual Report
Feb 27, 2024
8-K
Current Report

Peers (Alternatives to Chemed Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
454.7B
371.6B
-0.02% 1.44%
20.32
1.22
14.64% 11.24%
102.0B
195.3B
-1.02% 36.19%
18.98
0.52
8.17% -20.79%
87.3B
357.8B
-11.09% -5.71%
10.46
0.24
10.95% 93.52%
78.5B
65.0B
-10.17% 8.75%
14.98
1.21
7.86% -7.11%
39.5B
154.0B
-6.25% 10.48%
14.6
0.26
6.54% 124.79%
11.1B
12.1B
-8.86% 50.81%
15.99
0.91
4.57% 23.40%
10.6B
14.3B
-14.78% 11.99%
14.83
0.75
6.59% 6.24%
MID-CAP
9.0B
2.3B
-8.12% 6.65%
33.17
3.99
6.06% 9.17%
6.5B
2.9B
-10.43% -6.61%
-299.48
2.22
12.20% -107.93%
2.1B
3.8B
-13.87% -35.57%
10.12
0.56
-27.73% -52.50%
2.1B
1.4B
-7.13% -7.85%
33.88
1.48
21.19% 34.42%
SMALL-CAP
1.6B
1.1B
-3.48% -11.27%
25.19
1.49
11.31% 35.83%
1.2B
3.0B
2.35% 54.74%
-6.54
0.41
6.74% 20.73%
55.0M
-
-9.52% -10.68%
-3.76
-
- -12.94%
18.4M
21.3M
13.67% 2.11%
34.56
0.86
8.00% -62.25%

Chemed Corp News

Latest updates
MarketBeat • 45 hours ago
Defense World • 11 Apr 2024 • 09:47 am
Yahoo Finance • 03 Apr 2024 • 07:00 am
Investing.com • 01 Apr 2024 • 07:00 am
Investing.com • 22 Mar 2024 • 07:00 am
Zacks Investment Research • 2 months ago

Chemed Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue3.8%586565554560547526531531541539532527528528502516522481474462453
Costs and Expenses-0.7%475478484487465446439441443446461447390454409436445416408413390
  S&GA Expenses0.8%10010095.0010097.0084.0088.0090.0092.0089.0094.0092.0087.0088.0085.0071.0083.0077.0072.0074.0067.00
EBITDA Margin6.8%0.18*0.17*0.17*0.17*0.18*0.19*0.20*0.19*0.19*0.21*0.21*0.22*0.22*0.19*0.18*0.17*0.16*0.15*0.15*--
Interest Expenses-23.0%0.000.001.002.002.001.001.001.001.001.000.000.000.000.001.001.001.001.001.001.001.00
Income Taxes39.5%26.0018.0017.0017.0020.0020.0020.0021.0022.0023.0019.0018.0032.0014.0018.0013.0014.008.0014.006.008.00
Earnings Before Taxes23.9%11693.0070.0071.0082.0076.0086.0085.0096.0095.0075.0084.0014682.0010069.0080.0067.0064.0051.0063.00
EBT Margin8.5%0.15*0.14*0.14*0.15*0.15*0.16*0.17*0.16*0.16*0.19*0.18*0.20*0.19*0.16*0.16*0.14*0.13*0.13*0.13*--
Net Income20.1%90.0075.0053.0054.0062.0057.0066.0064.0075.0072.0057.0065.0011468.0082.0056.0066.0059.0051.0045.0054.00
Net Income Margin9.5%0.12*0.11*0.10*0.11*0.12*0.12*0.13*0.12*0.13*0.14*0.14*0.16*0.15*0.13*0.13*0.12*0.11*0.11*0.11*--
Free Cashflow460.4%97.0017.0011643.0082.0039.0044.0088.0049.001029.0089.0071.0011417669.0050.0011721.00--
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets6.8%1,6681,5621,5051,4311,4421,3561,3131,3061,3431,3181,3841,4581,4351,3671,2911,2781,2681,2331,0941,070976
  Current Assets26.9%501395337262273199203185230201269347329271189199191168180159160
    Cash Equivalents52.4%26417316058.0074.008.0010.0018.0033.0029.0092.0021016311320.0029.006.009.003.009.005.00
  Inventory-4.1%12.0013.0012.0011.0010.0010.0011.0011.0010.008.007.007.007.008.007.007.007.007.006.006.006.00
  Net PPE-0.8%204205208204200194192192194191193190188181183184176173150165162
  Goodwill0.0%585585582581581580580580579579579579579579578577577577511511511
Liabilities3.2%560543553551643635628639719538513529534566540594542560476482384
  Current Liabilities5.0%312297302283297298285280302286267290299329319247262252224217192
  Long Term Debt----16.0093.0096.00112120185------16090.0013085.0010089.00
    LT Debt, Current----5.005.005.005.00--------------
    LT Debt, Non Current----16.0093.0096.00112120185------16090.0013085.0010089.00
Shareholder's Equity8.7%1,1081,019952880799721685667623780871929901801751684727672619588591
  Retained Earnings3.6%2,4472,3632,2942,2462,1982,1412,0902,0291,9701,9011,8351,7841,7241,6151,5531,4761,4261,3651,3111,2651,226
  Additional Paid-In Capital6.9%1,3411,2541,2401,1861,1501,1001,0891,0641,0441,0081,000983961925904879861842817804774
Accumulated Depreciation-100.0%-348342338336338330326318311307299293289281279270264259254248
Shares Outstanding0.1%15.0015.0015.0015.0015.0015.0015.0015.0016.0016.0016.0016.0016.0016.0016.0016.0016.0016.0016.00--
Float---8,050---6,872---7,332---7,056---5,635--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations275.3%108,56328,927132,31760,492100,19952,01756,580101,09063,570112,98825,320106,71986,877124,590188,49689,32663,604128,73835,32273,58556,530
Cashflow From Investing24.4%-11,670-15,438-16,521-17,013-19,488-14,279-11,687-13,948-14,045-10,410-15,879-17,423-15,962-10,220-13,885-21,493-13,098-149,213-14,515-13,934-56,276
Cashflow From Financing-2213.7%-6,085-263-13,926-59,551-14,366-39,597-53,413-101,877-45,373-165,955-127,477-41,815-21,005-21,981-183,186-45,040-53,41426,218-26,252-55,714-62,882
  Dividend Payments0.4%6,0566,0345,7275,6855,6265,6695,4005,3225,5595,5935,4275,4375,4405,4015,1085,1305,1315,0904,7684,7994,812
  Buy Backs178.4%39,92814,344--12,97624,32549,42027,794245,662163,731125,54241,10728,47124,97521,913100,23520,705-22,67649,25036,908

CHE Income Statement

2023-12-31
Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Consolidated Statements Of Income [Abstract]   
Service revenues and sales (Note 2)$ 2,264,417$ 2,134,963$ 2,139,261
Cost of services provided and goods sold (excluding depreciation)1,465,6021,369,8771,369,458
Selling, general and administrative expenses395,120358,727366,727
Depreciation50,80249,10249,011
Amortization10,06310,07010,040
Other operating expenses (Note 20)2,2613,691987
Total costs and expenses1,923,8481,791,4671,796,223
Income from operations340,569343,496343,038
Interest expense(3,108)(4,584)(1,868)
Other income/(expense)--net (Note 10)12,906(9,233)9,144
Income before income taxes350,367329,679350,314
Income taxes (Note 11)(77,858)(80,055)(81,764)
Net income$ 272,509$ 249,624$ 268,550
Earnings Per Share (Note 16)   
Net income$ 18.11$ 16.72$ 17.14
Average number of shares outstanding15,05014,92915,671
Diluted Earnings Per Share (Note 16)   
Net income$ 17.93$ 16.53$ 16.85
Average number of shares outstanding15,20015,09915,938

CHE Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents (Note 9)$ 263,958$ 74,126
Accounts receivable181,511139,408
Inventories12,00410,272
Prepaid income taxes13,16618,515
Prepaid expenses30,20430,291
Total current assets500,843272,612
Investments of deferred compensation plans held in trust (Notes 15 and 17)106,12693,196
Properties and equipment, at cost, less accumulated depreciation (Note 13)203,840199,714
Lease right of use asset (Note 14)126,387135,662
Identifiable intangible assets less accumulated amortization (Note 6)90,26499,726
Goodwill585,017581,295
Other assets (Note 12)55,61859,807
Total Assets1,668,0951,442,012
Current liabilities  
Accounts payable64,03441,884
Current portion of long-term debt (Note 3) 5,000
Income taxes (Note 11)6,858 
Accrued insurance58,56858,515
Accrued compensation88,38187,350
Accrued legal6,3864,456
Short-term lease liability (Note 14)38,63538,996
Other current liabilities (Note 21)49,18861,004
Total current liabilities312,050297,205
Deferred income taxes (Note 11)30,32138,613
Long-term debt (Note 3) 92,500
Deferred compensation liabilities (Note 15)104,06992,330
Long-term lease liability (Note 14)100,776110,513
Other liabilities13,00312,136
Total Liabilities560,219643,297
Commitments and contingencies (Note 18)
STOCKHOLDERS' EQUITY  
Capital stock - authorized 80,000,000 shares $1 par; issued 37,183,681 shares (2022 - 36,795,792 shares)37,18436,796
Paid-in capital1,341,2731,149,899
Retained earnings2,446,9252,197,918
Treasury stock - 22,148,927 shares (2022 - 21,920,993 shares)(2,719,588)(2,588,145)
Deferred compensation payable in Company stock (Note 15)2,0822,247
Total Stockholders' Equity1,107,876798,715
Total Liabilities and Stockholders' Equity$ 1,668,095$ 1,442,012
CHE
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
 CEO
 WEBSITEchemed.com
 INDUSTRYHealthcare Plans
 EMPLOYEES14167

Chemed Corp Frequently Asked Questions


What is the ticker symbol for Chemed Corp? What does CHE stand for in stocks?

CHE is the stock ticker symbol of Chemed Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Chemed Corp (CHE)?

As of Thu Apr 18 2024, market cap of Chemed Corp is 9.04 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CHE stock?

You can check CHE's fair value in chart for subscribers.

What is the fair value of CHE stock?

You can check CHE's fair value in chart for subscribers. The fair value of Chemed Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Chemed Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CHE so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Chemed Corp a good stock to buy?

The fair value guage provides a quick view whether CHE is over valued or under valued. Whether Chemed Corp is cheap or expensive depends on the assumptions which impact Chemed Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CHE.

What is Chemed Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, CHE's PE ratio (Price to Earnings) is 33.17 and Price to Sales (PS) ratio is 3.99. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CHE PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Chemed Corp's stock?

In the past 10 years, Chemed Corp has provided 0.217 (multiply by 100 for percentage) rate of return.